To request a HRD test, please send a tumour tissue sample together with the completed test request form to one of the partner NHS Genomic Laboratory Hubs. It will be then forwarded to Myriad Genetics Inc. in the United States where the myChoice® CDx HRD test will be performed. The results will be returned to the GLH within 14-21 days for further dissemination to the requesting clinician.
The provision of the HRD testing service is funded by global co-promotion agreement between AstraZeneca & MSD. The service is delivered in accordance with arrangements agreed with NHS England and NHS Improvement and facilitated by NHS Genomic Laboratory Hubs.
To discuss HRD testing in the private sector, please contact us at: AZDiagnostics@astrazeneca.com.
The Myriad myChoice® CDx assay can identify patients as being HRD-positive by detecting tBRCA1/2 mutations and measuring genomic instability.2
Test request forms and contact information for the partner NHS Genomic Laboratory Hubs
Genetic Medicine (6th Floor), St. Mary's Hospital, Oxford Road, Manchester, M13 9WL
Tel: 0161 276 3265/6122
Pathology Sciences, Southmead Hospital, Southmead, Bristol, BS10 5NB
Tel: 0117 4146168
Bristol will only be taking samples from across the South West of England
Institute of Medical Genetics, University Hospital of Wales, Heath Park, Cardiff, CF14 4XW
Tel: 029 2184 2641
This content is valid for England, Wales and Northern Ireland; discussions for access to HRD testing in Scotland are ongoing. Updates to the website will be made periodically.